| Utility: Neurodevelopmental disorder therapy Filling date: 8 Sep 2025 Issue date: 20 Sep 2022 | 8 Jan 2021 | 20 Sep 2022 |
| Utility: ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL DISORDERS Filling date: 8 Sep 2025 Issue date: 11 Aug 2022 | 22 Jul 2020 | 11 Aug 2022 |
| Utility: OPTIMIZED SIGMA-1 AGONIST METHOD OF RESPONDER SELECTION AND TREATMENT Filling date: 8 Sep 2025 Issue date: 21 Jul 2022 | 20 May 2019 | 21 Jul 2022 |
| Utility: A2-73 as a therapeutic for insomnia, anxiety, and agitation Filling date: 8 Sep 2025 Issue date: 24 May 2022 | 27 Jul 2017 | 24 May 2022 |
| Utility: ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL DISORDERS Filling date: 8 Sep 2025 Issue date: 12 May 2022 | 21 Jan 2022 | 12 May 2022 |
| Utility: TREATMENT OF CARDIAC DYSFUNCTION Filling date: 8 Sep 2025 Issue date: 31 Mar 2022 | 26 Jul 2021 | 31 Mar 2022 |
| Utility: Anavex2-73 for the treatment of alzheimer's disease Filling date: 8 Sep 2025 Issue date: 31 Aug 2021 | 27 Sep 2019 | 31 Aug 2021 |
| Utility: Neurodevelopmental Disorder Therapy Filling date: 8 Sep 2025 Issue date: 29 Jul 2021 | 8 Jan 2021 | 29 Jul 2021 |
| Utility: Treatment of cardiac dysfunction Filling date: 8 Sep 2025 Issue date: 27 Jul 2021 | 22 Oct 2018 | 27 Jul 2021 |
| Utility: CRYSTAL FORMS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE HYDROCHLORIDE, PROCESSES OF MAKING SUCH FORMS, AND THEIR PHARMACEUTICAL COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 22 Jul 2021 | 5 Apr 2021 | 22 Jul 2021 |
| Utility: Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazi- ne and salts thereof Filling date: 8 Sep 2025 Issue date: 1 Jul 2021 | 12 Feb 2021 | 1 Jul 2021 |
| Utility: SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY Filling date: 8 Sep 2025 Issue date: 24 Jun 2021 | 28 Nov 2018 | 24 Jun 2021 |
| Utility: A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF MATTER AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 22 Apr 2021 | 12 Apr 2019 | 22 Apr 2021 |
| Utility: Crystal forms of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, processes of making such forms, and their pharmaceutical compositions Filling date: 8 Sep 2025 Issue date: 6 Apr 2021 | 29 Jul 2019 | 6 Apr 2021 |
| Utility: A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION Filling date: 8 Sep 2025 Issue date: 25 Mar 2021 | 27 Jul 2017 | 25 Mar 2021 |
| Utility: Analgesic therapeutic and method, 1-(3-4(((1 R,3S,5S)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine and salts thereof Filling date: 8 Sep 2025 Issue date: 2 Mar 2021 | 4 Feb 2019 | 2 Mar 2021 |
| Utility: A19-144, A2-73 and Certain Anticholinesterase Inhibitor Compositions and Method for Anti-Seizure Therapy Filling date: 8 Sep 2025 Issue date: 18 Feb 2021 | 26 Oct 2020 | 18 Feb 2021 |
| Utility: Neurodevelopmental disorder therapy Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 | 17 Dec 2019 | 12 Jan 2021 |
| Utility: A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method for anti-seizure therapy Filling date: 8 Sep 2025 Issue date: 27 Oct 2020 | 14 Oct 2019 | 27 Oct 2020 |
| Utility: Neurodevelopmental Disorder Therapy Filling date: 8 Sep 2025 Issue date: 6 Aug 2020 | 17 Dec 2019 | 6 Aug 2020 |
| Utility: A19-144, A2-73 and Certain Anticholinesterase Inhibitor Compositions and Method for Anti-Seizure Therapy Filling date: 8 Sep 2025 Issue date: 6 Feb 2020 | 14 Oct 2019 | 6 Feb 2020 |
| Utility: Anavex2-73 for the Treatment of Alzheimer's Disease Filling date: 8 Sep 2025 Issue date: 23 Jan 2020 | 27 Sep 2019 | 23 Jan 2020 |
| Utility: Neurodevelopmental disorder therapy Filling date: 8 Sep 2025 Issue date: 17 Dec 2019 | 24 Jan 2017 | 17 Dec 2019 |
| Utility: CRYSTAL FORMS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE HYDROCHLORIDE, PROCESSES OF MAKING SUCH FORMS, AND THEIR PHARMACEUTICAL COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 21 Nov 2019 | 29 Jul 2019 | 21 Nov 2019 |
| Utility: A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method for anti-seizure therapy Filling date: 8 Sep 2025 Issue date: 15 Oct 2019 | 19 Oct 2015 | 15 Oct 2019 |
| Utility: Crystalline form of ANAVEX2-73 for the treatment of Alzheimer's disease Filling date: 8 Sep 2025 Issue date: 1 Oct 2019 | 14 Jun 2017 | 1 Oct 2019 |
| Utility: Crystal forms of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, processes of making such forms, and their pharmaceutical compositions Filling date: 8 Sep 2025 Issue date: 17 Sep 2019 | 19 Jul 2016 | 17 Sep 2019 |
